FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

GALLISPAT

56.15
-1 (-1.75%)
Updated 03:28 23/07 IST

GALLISPAT Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for GALLISPAT
Disclaimer
0% Bullish
0% Bearish

GALLISPAT Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See GALLISPAT Share Price Targets >>

GALLISPAT Ratings

Long term GALLISPAT rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live GALLISPAT message board: Is GALLISPAT buy or sell? Should I buy GALLISPAT shares? Why are GALLISPAT shares falling? Should I invest in GALLISPAT stock?

  1. Home
  2. GALLISPAT Forum

GALLISPAT Share Price Discussion

H
Reputation: 0 • Jun 29 7:33 AM

Type
Buy
Instrument
GALLISPAT
Entry Price
₹57
Price@Trade
₹57.25
Target Price
₹100
Stop Price
₹45
Valid Till
Jun 29, 2022 3:20 AM
Margin
₹57,000 approx for 1000 Qty
Status
Waiting for entry

Like
Reply
swap_vert
Trade
D
Reputation: 0 • May 7 5:14 AM

Type
Buy
Instrument
GALLISPAT
Entry Price
₹48
Price@Trade
₹48.5
Target Price
₹56
Stop Price
₹45
Valid Till
May 6, 2022 3:20 AM
Margin
₹120,000 approx for 2500 Qty
Status
Target Achieved
Exit Price
₹56
Net P&L
+₹20,000 (+16.67%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
May 7 5:18 AM

Update
Trade Entered
Entry Price
₹48
TrackerBot @trackerbot
May 10 5:21 AM

Update
Target Achieved
Exit Price
₹56
D
Reputation: 0 • May 7 5:11 AM

Type
Buy
Instrument
GALLISPAT
Entry Price
₹47
Price@Trade
₹47.75
Target Price
₹56
Stop Price
₹45
Valid Till
May 6, 2022 3:20 AM
Margin
₹94,000 approx for 2000 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
Divya @djm
May 7 5:14 AM

Update
Exited before entry
Price @ Update
₹48.5
N
Reputation: 14,787 • Mar 8 6:58 AM
Why Pharma Sales Function Has Too Few Women?
Though the marketing and sales division has traditionally given pharma sector its leaders, women are still a small percentage here. A pharma association data says that while the average percentage of women in most sectors in India is between 15- 35%, in the pharma industry, it is 10–15%.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Feb 7 8:34 AM
GlaxoSmithKline Pharmaceuticals Reports Net Profit Of Rs 157 Crore In Q3
Revenue from operations rose by 10 per cent to Rs 857.20 crore during the third quarter as against Rs 778.59 crore in the year-ago period, the company said in a regulatory filing.
Moneycontrol
Like
Reply

Type
Buy
Instrument
GALLISPAT
Entry Price
₹37
Price@Trade
₹37
Target Price
₹100
Stop Price
₹0
Valid Till
Dec 23, 2021 3:20 AM
Margin
₹92,500 approx for 2500 Qty
Status
Exited
Exit Price
₹44.3
Net P&L
+₹18,250 (+19.73%)
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited
Exit Price
₹44.3
Net P&L
+₹18,250 (+19.73%)
N
Reputation: 14,787 • Oct 28, 2020 2:13 AM
GlaxoSmithKline Pharma Q2 net profit declines 85% to Rs 76.47 crore
The company has recognised a financial impact of Rs 64.13 crore for the latest September quarter mainly to reflect the estimated realisable value of the assets, associated costs and impacts of reversal of provision on account of Zinetac recall, the filing said.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Jul 29, 2020 4:33 AM
GlaxoSmithKline Standalone June 2020 Net Sales at Rs 648.65 crore, down 17.69% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Jul 29, 2020 4:33 AM
GlaxoSmithKline Consolidated June 2020 Net Sales at Rs 648.59 crore, down 17.69% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Jul 29, 2020 1:43 AM
GlaxoSmithKline Pharmaceuticals Q1 net profit declines 2.38% to Rs 111 crore
The company had posted a net profit of Rs 113.54 crore in the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Jun 29, 2020 4:03 AM
Immunity booster for your portfolio! Here's a list of 10 stocks to get through COVID times
India's long-term fundamental stories for discretionary and consumption are intact, and sectors such as IT, Pharmaceuticals, Bank, Cement, Gas, Capital Goods, and insurance are expected to be the new leaders.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • Jun 11, 2020 10:43 AM
GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy
GSK is betting on its adjuvant technology to support companies developing COVID-19 vaccines.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • May 21, 2020 2:48 AM
GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 14,787 • May 19, 2020 3:28 AM
GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 14,787 • May 18, 2020 2:18 AM
GlaxoSmithKline Pharma Q4 net profit declines 6% to Rs 138 crore
For the fiscal year ended March this year, the company posted a net profit of Rs 93.20 crore as against Rs 445.39 crore in the previous fiscal, the filing said.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • May 7, 2020 8:23 AM
GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever
The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.
Moneycontrol
Like
Reply
N
Reputation: 14,787 • May 5, 2020 12:58 PM
Hot Stocks | Glaxo Pharma, M&M, Tata Comm three buy ideas for short term
In the week gone by, Nifty took out the crucial resistance of 9,390, which will interchange its role as immediate resistance.
Moneycontrol
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • GALLISPAT - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization851.44
    Enterprise Value1,090.09
    Price to Earnings14.12
    Price to Book Value1.11
    Return on Capital Employed0.11
    Return on Equity0.12
    Face Value1
    Dividend YieldNA
  • GALLISPAT Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 2357.1558.3555.656.4
    Jul 2256.758.454.2557.15
    Jul 205757.554.155.15
    Jul 1955.957.4554.656.6
    Jul 1657.657.65656.6
  • GALLISPAT Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹55.59
    30 Day Moving Average₹54.25
    50 Day Moving Average₹52.53
    100 Day Moving Average₹46.93
    200 Day Moving Average₹40.04
  • GALLISPAT - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue575424.710.35
    Operating Profit9252.150.76
    Profit Before Tax6746.050.45
    Net Income5444.250.22
  • GALLISPAT - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds7644460.71
    Total Liabilities284563-0.5
    Total Assets1,0481,0100.04
  • GALLISPAT - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity7619.172.96
    Cash from Investing Activity-157-32.913.77
    Cash from Financing Activity8111.915.8
    Net Cash FlowNA-1.83-1
  • GALLISPAT - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.06
    Return on Equity0.120.11
    Return on Capital Employed0.110.11
  • GALLISPAT - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit0.78
    3 Year CAGR Growth in EBIDTA0.73
    3 Year CAGR Growth in Net Income0.99
    3 Yr CAGR Growth - Diluted EPS-0.8
  • GALLISPAT - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.4
    5 Year CAGR Growth in Operating Profit2.05
    5 Year CAGR Growth in EBIDTA0.78
    5 Year CAGR Growth in Net Income3.6
    3 Yr CAGR Growth - Diluted EPS3.37
  • GALLISPAT - Recent News

    keyboard_arrow_down
    NewsBot
    Mar 8 6:58 AM
    Why Pharma Sales Function Has Too Few Women?
    Moneycontrol
    NewsBot
    Feb 7 8:34 AM
    GlaxoSmithKline Pharmaceuticals Reports Net Profit Of Rs 157 Crore In Q3
    Moneycontrol
    NewsBot
    Nov 2, 2020 12:23 PM
    NewsBot
    Oct 29, 2020 4:18 AM
    NewsBot
    Oct 29, 2020 3:28 AM
    NewsBot
    Oct 28, 2020 2:13 AM
    GlaxoSmithKline Pharma Q2 net profit declines 85% to Rs 76.47 crore
    Moneycontrol
    NewsBot
    Jul 29, 2020 4:33 AM
    GlaxoSmithKline Standalone June 2020 Net Sales at Rs 648.65 crore, down 17.69% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 29, 2020 4:33 AM
    GlaxoSmithKline Consolidated June 2020 Net Sales at Rs 648.59 crore, down 17.69% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 29, 2020 1:43 AM
    GlaxoSmithKline Pharmaceuticals Q1 net profit declines 2.38% to Rs 111 crore
    Moneycontrol
    NewsBot
    Jun 11, 2020 10:43 AM
    GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy
    Moneycontrol
  • GALLISPAT - Related Communities

    keyboard_arrow_down
    Tata Steel Ltd. NSE: TATASTEEL | BSE:...
    JSW Steel Ltd. NSE: JSWSTEEL | BSE: 5...
    Jindal Steel & Power Ltd. NSE: JINDAL...
    Steel Authority of India Ltd. NSE: SA...
    Jindal Saw Ltd. NSE: JINDALSAW | BSE:...
    Tata Steel BSL Ltd NSE: TATASTLBSL | ...
    Mishra Dhatu Nigam Ltd. NSE: MIDHANI ...
    Welspun Corp Ltd. NSE: WELCORP | BSE:...
    Tata Metaliks Ltd. NSE: TATAMETALI | ...
    Tata Steel Long Products Ltd. NSE: TA...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020